FDA Inspection
LGM Pharma Solutions, LLCLGM Pharma Solutions, LLC – FDA Inspection, May 18, 2026
Record Details
This FDA Inspection record concerns LGM Pharma Solutions, LLC, with an inspection on May 18, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 862f3c9a-5369-473a-b4fe-259a971eb45c
Inspection Facts
- Inspection number
- 1317740
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LGM Pharma Solutions, LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 17, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| October 20, 2017 | Not classified | Los Angeles District Office | Generic Drug Evaluation |
Other documents for LGM Pharma Solutions, LLC
- FDA Inspection 1232056 - 2025-01-24
- FDA Inspection 1230374 - 2024-03-01
- FDA Inspection 1120565 - 2020-01-31
- FDA Inspection 1062404 - 2018-08-17
- FDA Inspection 1029466 - 2017-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.